Skip to main content

. 1957 Jan;47(1):1–18. doi: 10.2105/ajph.47.1.1

Poliomyelitis Vaccination in the Fall of 1956

PMCID: PMC1551087 PMID: 13381837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CORNFIELD J., HALPERIN M., MOORE F. Some statistical aspects of safety testing the Salk poliomyelitis vaccine. Public Health Rep. 1956 Oct;71(10):1045–1056. [PMC free article] [PubMed] [Google Scholar]
HULL R. N., MINNER J. R., SMITH J. W. New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents S.V.1, S.V.2, S.V.4, S.V.5, S.V.6, S.V.11, S.V.12 and S.V.15. Am J Hyg. 1956 Mar;63(2):204–215. doi: 10.1093/oxfordjournals.aje.a119804. [DOI] [PubMed] [Google Scholar]
MACLEOD C. M. Relation of the incubation period and the secondary immune response to lasting immunity to infectious diseases. J Immunol. 1953 Apr;70(4):421–425. [PubMed] [Google Scholar]
SALK J. E. Considerations in the preparation and use of poliomyelitis virus vaccine. J Am Med Assoc. 1955 Aug 6;158(14):1239–1248. doi: 10.1001/jama.1955.02960140001001. [DOI] [PubMed] [Google Scholar]
SALK J. E. Requirements for persistent immunity to poliomyelitis. Am J Med Sci. 1956 Oct;232(4):369–377. doi: 10.1097/00000441-195610000-00001. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES